Trial intelligence / Profile preview

Mixed RI colloid and dye for sentinel lymph node navigation in gastric cancer surgery

jRCTs031230237Completed

Sponsor
Clinical Research Initiation-Fund (of Chiba University Hospital)
Start
Jul 2023
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals
Countries
1
01

Overview

Open-label, single-arm trial of indocyanine green and technetium-99m-tin colloid in gastric cancer (GC), sponsored by Clinical Research Initiation-Fund (of Chiba University Hospital). Primary endpoint: Adverse events related to investigational drug. Started Jul 2023; status: completed.

02

Drugs

indocyanine greentechnetium-99m-tin colloid
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on jRCTs031230237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031230237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call